Published Research 2019 REALITY PROGRESS Optimizing Diabetes Selfmanagement Using the Novel Skills, Confidence, and Preparedness Index (SCPI) Paradoxical Rise in Hypoglycemia Symptoms With Development of Hyperglycemia During HighIntensity Interval Training in Type 1 Diabetes Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials Eversense Pediatric 180 day study Diabetes Obesity Metabolism FIT Study: Optimal Insulin Correction of Post High Intensity Exercise Hyperglycemia in Adults with Type 1 Diabetes (Diabetes Care) FIT study: Reproducibility of Cardiometabolic Response to High Intensity Exercise in Type 1 Diabetes (Diabetes Research and Clinical Practice) FIT Study: Accuracy of Continuous Glucose Monitoring during High Intensity Exercise in Type 1 Diabetes (Diabetes Technology & Therapeutics) 2018 ALT in SGLT2 inhibitors and incretin agents (Diabetes & Metabolism) 2017 GIFT Study The LMC Skills, Confidence & Preparedness Index (SCPI) Dapagliflozin Real-World Evidence (Diabetes Technology & Therapeutics) The LMC Skills, Confidence & Preparedness Index (SCPI) 2.0 (Diabetes Research & Clinical Practice) 2016 The NADIR Study (Canadian Journal of Diabetes) The Global HAT Study The OpT2mise Randomized Trial DROP A1C (Diabetes Care) INNOVATE Trial (Diabetes Technology & Therapeutics) 2015 The Elixa and Tecos Trial (ADA 2015 Meeting Report) Predictors of Poor Glycemic Control in Type 2 Diabetes (Journal of Diabetes)
